跳至主要内容

Gene Knockout Technology Service Company

 The Medicilon gene knockout service has been successfully applied to model organisms such as cells, yeast, plants, zebrafish, mice, and rats. Gene knock-out is a technique for the targeted integration of foreign genes into a certain location on the genome of target cells through homologous recombination to achieve the purpose of targeted modification of a gene on a chromosome. It overcomes the blindness and chance of random integration, and is an ideal method to modify and transform biological genetic material.

Gene knockout service

  • CRISPR/Cas9 gene knockout mouse technical service

Technical process: gRNA vector construction =>”gRNA and Cas9 transcribed into mRNA in vitro => “mRNA microinjection (produced by F0 model)

Provide the following technical services:

  •     All-inclusive services from gRNA vector construction to F0 model production
  •     Customers provide Cas9 RNA and gRNA that meet quality requirements for subsequent microinjection and model production
Gene knockout service
  • Traditional ES target gene knockout/knock-in mouse technical service

Technical process: Targeting vector design and construction => “ES electrotransfer and positive clone screening => “ES microinjection and chimera preparation =>”F1 generation mouse reproduction and identification

Provide the following technical services: complete gene knockout mice, conditional gene knockout mice, gene knock-in mice

What is a knockout mice model?

After knocking out one or more of all the 30,000 genes in the mouse, the cultured mouse becomes an animal model suitable for drug clinical trials, which can imitate human patients for research and treatment. For example, there is a key link in pharmaceutical research and development, which is animal experiments. In order to study drugs for treating cancer, a mouse model of cancer is required; in order to study diabetes, a mouse model of diabetes is required.

knockout mouse steps
knockout mouse steps

How do you make a knockout mouse?

  1. Obtaining ES cells
  2. Construction of gene vector
  3. Introduction of the target gene
  4. Screen the hit cells with selective medium
  5. By observing the changes in the biological shape of the chimeric mice and then understanding the changes in the biological shape of the mice before and after the change of the target gene, the purpose of studying the target gene is achieved.

Application areas of gene knockout

  1. Establish a transgenic animal model of human diseases to provide materials for medical esearch
  2. Transform animal genotypes, identify new genes and/or their new functions, and study developmental biology
  3. Treatment of genetic diseases
  4. Transform organisms and cultivate new biological varieties

Related Articles:

Knockout Gene Model Has a Nose for Knockout Breath

Distract DNA Repair to Cinch CRISPR Knockout

标签：

评论

发表评论

此博客中的热门博文

What is preclinical testing?

In the process of  preclinical testing  of a compound or biological agent into a drug, the compound involved must go through the testing phase. First, we need to identify potential targets that can treat the disease. Then, a variety of compounds or preparations are screened out. Any compound that has shown potential as a drug for the treatment of this disease needs to be tested for toxicity before clinical testing to reduce the possibility of injury. preclinical testing What is the basis of preclinical testing? According to US Food and Drug Administration (FDA) regulations, a series of tests are required before a new drug is approved for use. In the first stage, basic research determines a hypothetical target for the treatment of a certain disease, and then screens small molecules or biological compounds to discover any substance with the potential to treat the disease. Then, a  preclinical research  phase followed, before which, as described above, the potential toxicity of the compou
发表评论
阅读全文

Inventory of the three major in vitro pharmacokinetic research methods

  The metabolic properties of a compound are an essential factor in whether or not it can be used as a drug in the clinical setting, so pharmacokinetic studies of newly synthesized compounds are required in drug development. In vitro incubation with liver microsomes, recombinant CYP450 enzyme lines, and in vitro incubation with hepatocytes are some of the more common in vitro drug metabolism methods. 1. In vitro incubation method with liver microsomes The metabolic stability and metabolic phenotypes of candidate compounds in different species of liver microsomes are good predictors of the metabolic properties of compounds in vivo. They are practical tools for evaluating candidate compounds in the pre-development phase of drug development. Liver microsomes include rat liver microsomes, human liver microsomes, canine liver microsomes, monkey liver microsomes, and mouse liver microsomes. In in vitro incubation of the liver, microsomes are the "gold standard" for in vitro d
发表评论
阅读全文

Novel Parkinson’s Therapies Possible with New Mouse Model

Parkinson's disease (PD) is a neurodegenerative disorder that is marked by the accumulation of the protein, α-synuclein (αS), into clumps known as Lewy bodies, which diminish neural health. Now, researchers from Brigham and Women's Hospital (BWH) report the development of a mouse model to induce PD-like αS aggregation, leading to resting tremor and abnormal movement control. The mouse responds to L-DOPA, similarly to patients with PD. The team's study (“Abrogating Native α-Synuclein Tetramers in Mice Causes a L-DOPA-Responsive Motor Syndrome Closely Resembling Parkinson’s Disease”) on the use of this transgenic mouse model appears in  Neuron . “α-Synuclein (αS) regulates vesicle exocytosis but forms insoluble deposits in PD. Developing disease-modifying therapies requires animal models that reproduce cardinal features of PD. We recently described a previously unrecognized physiological form of αS, α-helical tetramers, and showed that familial PD-causing missense mutati
发表评论
阅读全文